These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4170766)

  • 1. [Effect of desferrioxamine B on tissue sections of hemosiderosis of the kidney].
    Althoff H
    Arzneimittelforschung; 1966 Jun; 16(6):768-71. PubMed ID: 4170766
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion hemosiderosis. Report of a case treated with desferrioxamine-B.
    Kaung DT
    J Iowa Med Soc; 1965 Jun; 55(6):312-6. PubMed ID: 5835475
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic renal failure due to renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria.
    Zachée P; Henckens M; Van Damme B; Boogaerts MA; Rigauts H; Verberckmoes RK
    Clin Nephrol; 1993 Jan; 39(1):28-31. PubMed ID: 8428404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of desferrioxamine B. A new iron eliminating agent, on cases of secondary haemosiderosis in children.
    el-Gholmy A; Khalifa AS; Rahman YA; el-Bagoury I
    J Trop Med Hyg; 1969 Jan; 72(1):22-6. PubMed ID: 5773810
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital erythroblastic hypoplasia. Treatment of transfusion hemosiderosis with desferrioxamine B.
    Hildner FJ; Monto RW; Rebuck JW
    Henry Ford Hosp Med J; 1968; 16(2):147-55. PubMed ID: 5650037
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
    Orsini A; Raybaud C; Bernard PJ; Aquaron R; Passeron P
    Mars Med; 1967; 104(4):331-7. PubMed ID: 5621537
    [No Abstract]   [Full Text] [Related]  

  • 7. [Massive renal hemosiderosis in Marchiafava anemia and the possibility of an in-vitro desferrization through desferriofamine B].
    Althoff H
    Gegenbaurs Morphol Jahrb; 1967; 111(2):292-300. PubMed ID: 5588144
    [No Abstract]   [Full Text] [Related]  

  • 8. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
    Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
    Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of desferrioxamine on iron elimination in children after multiple transfusions].
    Leggio ML
    Minerva Pediatr; 1966 Feb; 18(3):101-3. PubMed ID: 5930397
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on iron metabolism with desferrioxamine in man. Experimental and clinical studies.
    Hedenberg L
    Scand J Haematol Suppl; 1969; 6():5-86. PubMed ID: 5259199
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nocturanl paroxysmal hemoglobinuria. II. Renal insufficiency in the course of the same (clinical, histological and ultramicroscopic study of the renal pathology and of its development after desferrioxamine therapy)].
    Tejero Lamarca J; Yangüela Terroba J; Diáz-Flores L
    Rev Clin Esp; 1973 Feb; 128(4):287-98. PubMed ID: 4700581
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis and therapy of iron overload with desferrioxamine].
    Andres J; Stobbe H
    Z Gesamte Inn Med; 1984 Apr; 39(8):167-9. PubMed ID: 6730593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion haemosiderosis and chelation therapy.
    Ley TJ; Griffith P; Nienhuis AW
    Clin Haematol; 1982 Jun; 11(2):437-64. PubMed ID: 7042160
    [No Abstract]   [Full Text] [Related]  

  • 14. [Demonstration of increased iron storage in the organism with desferrioxamine (desferal test)].
    Schnack H; Wewalka F
    Med Welt; 1965 Jul; 27():1529-35. PubMed ID: 5838535
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous high-dose intravenous desferrioxamine treatment for iron overload.
    Sidi Y; Shaklai M; Liban E; Pinkhas J
    Isr J Med Sci; 1981 May; 17(5):348-51. PubMed ID: 7263191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The anatomic lesions in nocturnal paroxysmal hemoglobinuria].
    Reynes M; Diebold J; Caulet T; Camilleri JP; Delarue J
    Arch Anat Pathol (Paris); 1969 Jun; 17(2):79-86. PubMed ID: 5345311
    [No Abstract]   [Full Text] [Related]  

  • 17. [The desferrioxamine test in patients with kidney diseases].
    Pannacciulli I; Paravidino GF; Siccardi G
    Minerva Med; 1971 Feb; 62(15):683-90. PubMed ID: 5549142
    [No Abstract]   [Full Text] [Related]  

  • 18. CONGENITAL ERYTHROBLASTIC HYPOPLASIA; TREATMENT OF TRANSFUSION HEMOSIDEROSIS WITH DESFERRIOXAMINE B.
    HILDNER FJ; MONTO RW; REBUCK JW
    Henry Ford Hosp Med Bull; 1964 Mar; 12():5-13. PubMed ID: 14129631
    [No Abstract]   [Full Text] [Related]  

  • 19. Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship.
    Silliman CC; Peterson VM; Mellman DL; Dixon DJ; Hambidge KM; Lane PA
    J Lab Clin Med; 1993 Jul; 122(1):48-54. PubMed ID: 8320490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
    Ferrara M; Galdo Capotorti M; Ponte G; Esposito L
    Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.